Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshiharu Yanagi is active.

Publication


Featured researches published by Toshiharu Yanagi.


Journal of Organic Chemistry | 2009

Supramolecular Complexation and Enantiodifferentiating Photocyclodimerization of 2-Anthracenecarboxylic Acid with 4-Aminoprolinol Derivatives as Chiral Hydrogen-Bonding Templates

Yuko Kawanami; Tamara C. S. Pace; Jun-ichi Mizoguchi; Toshiharu Yanagi; Masaki Nishijima; Tadashi Mori; Takehiko Wada; Cornelia Bohne; Yoshihisa Inoue

The photochirogenesis of 2-anthracenecarboxylic acid (AC) complexed to a hydrogen-bonding template (TKS159) was investigated to obtain mechanistic information on how chirogenesis is achieved for the dimerization of AC. Complexation of AC to TKS159 leads to the shielding of one of the two surfaces of the prochiral AC molecule. The two diastereomeric AC-TKS complexes, i.e., re-AC-TKS and si-AC-TKS, were characterized by changes in the UV-vis, fluorescence, and circular dichroism spectra and excited-state lifetimes. The ee is not simply determined by the diastereomeric ratio of the re- and si-AC-TKS complexes but also depends on the relative lifetimes of the diastereomeric complexes. The relative population of the re and si complexes was calculated from the enantiomeric excess (ee) for the products, taking into account the relative lifetimes of the two complexes. These studies established a protocol that can be used to reveal the mechanism for photochirogenesis by investigating the ground state and the excited state behavior of supramolecular systems.


Antimicrobial Agents and Chemotherapy | 2006

In Vitro Activity of a Novel Antimicrobial Agent, TG44, for Treatment of Helicobacter pylori Infection

Osamu Kamoda; Kinsei Anzai; Jun-ichi Mizoguchi; Masatoshi Shiojiri; Toshiharu Yanagi; Takeshi Nishino; Shigeru Kamiya

ABSTRACT Due to concerns about the current therapeutic modalities for Helicobacter pylori infection, e.g., the increased emergence of drug-resistant strains and the adverse reactions of drugs currently administered, there is a need to develop an anti-H. pylori agent with higher efficacy and less toxicity. The antibacterial activity of TG44, an anti-H. pylori agent with a novel structural formula, against 54 clinical isolates of H. pylori was examined and compared with those of amoxicillin (AMX), clarithromycin (CLR), and metronidazole (MNZ). Consequently, TG44 inhibited the growth of H. pylori in an MIC range of 0.0625 to 1 μg/ml. The MIC ranges of AMX, CLR, and MNZ were 0.0078 to 8 μg/ml, 0.0156 to 64 μg/ml, and 2 to 128 μg/ml, respectively. The antibacterial activity of TG44 against AMX-, CLR-, and MNZ-resistant strains was nearly comparable to that against drug-susceptible ones. In a pH range of 3 to 7, TG44 at 3.13 to 12.5 μg/ml exhibited potent bactericidal activity against H. pylori in the stationary phase of growth as early as 1 h after treatment began, in contrast to AMX, which showed no bactericidal activity at concentrations of up to 50 μg/ml at the same time point of treatment. TG44 at 25 μg/ml exhibited no antibacterial activity against 13 strains of aerobic bacteria, suggesting that its antibacterial activity against H. pylori is potent and highly specific. The present study indicated that TG44 possesses antibacterial activity which manifests quickly and is potentially useful for eradicating not only the antibiotic-susceptible but also the antibiotic-resistant strains of H. pylori by monotherapy.


Carbohydrate Research | 2006

Two-dimensional 13C-1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose (β-cyclodextrin) with a new Helicobacter pylori eradicating agent (TG44) in the amorphous state

Kinsei Anzai; Hiroyuki Kono; Jun Ichi Mizoguchi; Toshiharu Yanagi; Fumitoshi Hirayama; Hidetoshi Arima; Kaneto Uekama


Chemical & Pharmaceutical Bulletin | 2007

Improvement of Dissolution Properties of a New Helicobacter pylori Eradicating Agent (TG44) by Inclusion Complexation with β-Cyclodextrin

Kinsei Anzai; Jun Ichi Mizoguchi; Toshiharu Yanagi; Fumitoshi Hirayama; Hidetoshi Arima; Kaneto Uekama


Archive | 1996

CYCLOHEXANE CARBOCYCLIC ESTER DERIVATIVE AND CYCLODEXTRIN COMPLEX AND COMPOSITION FOR TREATMENT OF HELICOBACTER PYLORI INFECTIONS

Osamu Kamoda; Toshiharu Yanagi; Eiji Tamaki; Seiji Sato; Jun-ichi Mizoguchi


Archive | 1995

Guanidinomethyl cyclohexane carboxylic acid ester derivatives

Osamu Kamoda; Hiromichi Fujiwara; Toshiharu Yanagi


Chemical & Pharmaceutical Bulletin | 1999

Synthesis and pharmacological activity of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4- pyrrolidinyl]benzamide (TKS159) and its optical isomers.

Toshiharu Yanagi; Akihiko Kitajima; Kinsei Anzai; Kazuya Kodama; Jun-ichi Mizoguchi; Hiromichi Fujiwara; Hideyo Sakiyama; Osamu Kamoda; Chiaki Kamei


Chemical & Pharmaceutical Bulletin | 2000

Preparation and Characterization of Two Crystalline Forms of 4-Amino-5-chloro-2-methoxy-N-[(2S, 4S)-1-ethyl-2-hydroxymethyl-4-pyrrolidinyl]benzamide (TKS159)

Toshiharu Yanagi; Jun-ichi Mizoguchi; Tsutomu Adachi; Seiji Sato; Kazuya Kodama; Kinsei Anzai; Yasushi Takagishi; Chiaki Kamei; Manabu Fujiwara; Takayuki Matsushita; Yuko Yamashoji; Yoshihisa Inoue


Archive | 2012

Method for producing optically active compound or salt thereof

Osamu Onomura; Yutaro Tsuda; Masami Kuriyama; Toshiharu Yanagi; Kazuya Kodama


Archive | 1996

Drug against helicobacter pylori

Osamu Kamoda; Jun-ichi Mizoguchi; Seiji Sato; Eiji Tamaki; Toshiharu Yanagi

Collaboration


Dive into the Toshiharu Yanagi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazuya Kodama

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge